References
- Campbell, G., Darke, S., Bruno, R., & Degenhardt, L. (2015). The prevalence and correlates of chronic pain and suicidality in a nationally representative sample. Australian and New Zealand Journal of Psychiatry, 49(9), 803–811. doi:10.1177/0004867415569795
- Centers for Disease Control and Prevention. (2006). Toxicology testing and results for suicide victims—13 states, 2004. MMWR: Morbidity and Mortality Weekly Report, 55(46), 1245–1248.
- Dalton, E. J., Cate–Carter, T. D., Mundo, E., Parikh, S. V., & Kennedy, J. L. (2003). Suicide risk in bipolar patients: The role of co‐morbid substance use disorders. Bipolar Disorders, 5(1), 58–61. doi:10.1034/j.1399-5618.2003.00017.x
- Green, C. A., Yarborough, M. T., Polen, M. R., Janoff, S. L., & Yarborough, B. J. H. (2015). Dual recovery among people with serious mental illnesses and substance problems: A qualitative analysis. Journal of Dual Diagnosis, 11(1), 33–41. doi:10.1080/15504263.2014.975004
- Kontaxakis, V. P., Christodoulou, G. N., Mavreas, V. G., & Havaki-Kontaxaki, B. J. (1988). Attempted suicide in psychiatric outpatients with concurrent physical illness. Psychotherapy and Psychosomatics, 50(4), 201–206. doi:10.1159/000288121
- Lopez-Castroman, J., Cerrato, L., Beziat, S., Jaussent, I., Guillaume, S., & Courtet, P. (2016). Heavy tobacco dependence in suicide attempters making recurrent and medically serious attempts. Drug and Alcohol Dependence, 160, 177–182. doi:10.1016/j.drugalcdep.2016.01.004
- Malone, K. M., Waternaux, C., Haas, G. L., Cooper, T. B., Li, S., & Mann, J. J. (2003). Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. American Journal of Psychiatry, 160(4), 773–779. doi:10.1176/appi.ajp.160.4.773
- Murphy, S. L., Kochanek, K. D., Xu, J., & Arias, E. (2015). Mortality in the United States, 2014. NCHS Data Brief, 229. Retrieved from http://www.cdc.gov/nchs/data/databriefs/db229.pdf
- Pettinati, H. M., Kampman, K. M., Lynch, K. G., Xie, H., Dackis, C., Rabinowitz, A. R., & Charles, P. O. (2008). A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence. Addictive Behaviors, 33(5), 651–667. doi:10.1016/j.addbeh.2007.11.011
- Sher, L. (2004). Preventing suicide. QJM, 97(10), 677–680. doi:10.1093/qjmed/hch106
- Tolliver, B. K., & Anton, R. F. (2015). Assessment and treatment of mood disorders in the context of substance abuse. Dialogues in Clinical Neuroscience, 17(2), 181.